InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,618.80
(
0.05%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.50
(
-0.45%
)
Bitcoin
62,457.11
(
0.20%
)
Post# of 642546
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1249
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Tuesday, 08/01/2023 8:52:16 AM

Tuesday, August 01, 2023 8:52:16 AM

Post# of 642546
(TCON) 0.29 - MC $7 m - pivotal interim data imminent (sarcoma drug) ...super cheap cancer play who could file NDA by mid next year

“We look forward to reporting the interim efficacy assessment from ENVASARC in the third quarter of 2023, which includes a futility analysis that we have already met based on responses seen to date.”
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up